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Abstract
Background: In the orofacial region, limited information is available concerning pathological tongue pain, such as
inflammatory pain or neuropathic pain occurring in the tongue. Here, we tried for the first time to establish a novel
animal model of inflammatory tongue pain in rats and to investigate the roles of metabotropic glutamate receptor
5 (mGluR5)-extracellular signal-regulated kinase (ERK) signaling in this process.
Methods: Complete Freund’s adjuvant (CFA) was submucosally injected into the tongue to induce the
inflammatory pain phenotype that was confirmed by behavioral testing. Expression of phosphorylated ERK (pERK)
and mGluR5 in the trigeminal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2) were detected with
immunohistochemical staining and Western blotting. pERK inhibitor, a selective mGluR5 antagonist or agonist was
continuously administered for 7 days via an intrathecal (i.t.) route. Local inflammatory responses were verified by
tongue histology.
Results: Submucosal injection of CFA into the tongue produced a long-lasting mechanical allodynia and heat
hyperalgesia at the inflamed site, concomitant with an increase in the pERK immunoreactivity in the Vc and C1-C2.
The distribution of pERK-IR cells was laminar specific, ipsilaterally dominant, somatotopically relevant, and
rostrocaudally restricted. Western blot analysis also showed an enhanced activation of ERK in the Vc and C1-C2
following CFA injection. Continuous i.t. administration of the pERK inhibitor and a selective mGluR5 antagonist
significantly depressed the mechanical allodynia and heat hyperalgesia in the CFA-injected tongue. In addition, the
number of pERK-IR cells in ipsilateral Vc and C1-C2 was also decreased by both drugs. Moreover, continuous i.t.
administration of a selective mGluR5 agonist induced mechanical allodynia in naive rats.
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Conclusions: The present study constructed a new animal model of inflammatory tongue pain in rodents, and
demonstrated pivotal roles of the mGluR5-pERK signaling in the development of mechanical and heat
hypersensitivity that evolved in the inflamed tongue. This tongue-inflamed model might be useful for future studies
to further elucidate molecular and cellular mechanisms of pathological tongue pain such as burning mouth
syndrome.
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Background
There are marked differences in pathological pain fol-
lowing tissue injury or inflammation between deep
and superficial tissues [1-3]. Orofacial deep tissue
(such as temporomandibular joint or masseter muscle)
inflammation produces a stronger excitation and/or
sensitization in the trigeminal nervous system com-
pared to cutaneous (such as perioral and facial skin)
inflammation [4-6]. Additionally, there are site-related
differences in pain processing between intraoral mu-
cosa and facial skin [7,8]. Indeed, these two kinds of
orofacial pain have been reported to differ in either
the morphology of primary afferent neurons [9] or the
somatotopy of trigeminal projections in the brainstem
[10]. However, few researchers have examined the dif-
ferences in mechanisms underlying intraoral mucosal
inflammatory pain compared with face inflammatory
pain [8,11,12].
Extracellular signal-regulated kinase (ERK), a member
of the mitogen-activated protein kinase (MAPK) family,
has been demonstrated to play a role in nociceptive
transmission, modulation and integration in neurons
[13,14]. ERK is phosphorylated following various nox-
ious stimuli, and phosphorylated ERK (pERK) affects the
neuronal excitability and pain processing [15-18]. In the
orofacial pain system, we have demonstrated that rostro-
caudal distribution of pERK-immunoreactive (IR) cells is
more extensive in the trigeminal spinal subnucleus cau-
dalis (Vc) and upper cervical spinal cord (C1-C2) after
capsaicin injection into the intraoral mucosa than facial
skin [12]. Using many different pain models, we further
show that pERK-IR neurons in the Vc and C1-C2 play
an important role in orofacial inflammatory or neuro-
pathic pain [11,19-24]. Hence, ERK phosphorylation is
among the possible mechanisms underlying pathological
pain following peripheral inflammation or nerve injury.
Moreover, ERK was phosphorylated in Vc neurons
within 5 to 10 min following noxious stimulation of the
facial skin and the number of pERK-IR cells increased
following increases in the noxious stimulus intensity, in-
dicating that ERK phosphorylation in Vc neurons could
be used as an excitable marker of nociceptive neurons
[20].
Subsequent to activation of primary sensory neurons,
glutamate is released from primary afferent terminals in
the spinal dorsal horn, and then ionotropic ligand-gated
glutamate receptors and G-protein-coupled metabotro-
pic glutamate receptors (mGluRs) are activated [25].
mGluR5, a subgroup of the mGluRs, is reported to be
highly expressed and thus involved in nociceptive pro-
cessing in the spinal dorsal horn [26-28]. Intrathecal (i.t.)
administration of the mGluR1/5 agonist induced spon-
taneous nocifensive behavior as well as thermal hyper-
algesia and allodynia in rats [29,30]. I.t. pretreatment
with the mGluR5 antagonist relieved inflammatory
hyperalgesia induced by complete Freund's adjuvant
(CFA) injection into the hind paw [26]. In addition, periph-
erally located mGluR5 has been shown to participate in the
generation of mechanical allodynia in either vibrissa pad
[31] or masseter muscle [32], while centrally located
mGluR5 is reported to contribute to the induction of long-
term potentiation of primary afferent synaptic transmission
in the Vc of juvenile rats [33]. Interestingly, evidence has
also been provided to reveal that mGluR5 modulates in-
flammatory nociceptive plasticity via downstream activation
of ERK signaling in the spinal cord [34-36].
Taken together, the aims of the present study are two-
fold. First is to establish a novel experimental model of
inflammatory tongue pain by submucosal injection of
CFA into the tongue. Second, we sought to test the hy-
pothesis that activation of mGluR5 is important for ERK
phosphorylation in Vc and C1-C2 neurons after tongue
inflammation and that this pathway is necessary for the
hyperexcitability of Vc and C1-C2 neurons following
CFA injection into the tongue, resulting in an enhance-




Adult male Sprague Dawley rats (200 to 250 g) were
used in this study (Japan SLC, Japan). Rats were exposed
to a 12 h light/dark cycle and kept in a temperature-
controlled room (23 ± 2°C) with food and water ad libi-
tum. This study was approved by the Animal Experi-
mentation Committee at Nihon University, and all
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experimental procedures were performed according to
the ethical guidelines of the International Association
for the Study of Pain [37]. All possible efforts were made
to minimize the number of animals used and their
suffering.
Drugs
The major drugs used in the current study were
PD98059 (EMD Biosciences, La Jolla, CA, USA), a well-
known MAPK kinase (MEK1/2) inhibitor [38], 2-methyl-
6-(phenylethynyl)-pyridine (MPEP, Sigma Aldrich, St.
Louis, MO, USA), a selective mGluR5 antagonist [39],
(RS)-2-Chloro-5-hydroxyphenylglycine (CHPG, Tocris,
Bristol, UK), a selective mGluR5 agonist [40] and CFA
(an inflammatory agent, Sigma Aldrich). PD98059 and
MPEP were initially dissolved in 100% dimethyl sulfoxide
(DMSO) as stock solutions (10 μg/μL) for frozen ali-
quots, and then further diluted to 0.1 μg/μL in 10%
DMSO (in 0.9% saline) for i.t. administration (see below).
A solution of 10% DMSO served as the vehicle control.
CHPG was diluted to 4.8 mM in 0.9% saline for i.t.
administration. For preparation of CFA solution, the
original drug was suspended in an oil/saline (1:1)
emulsion and stored at 4°C for subsequent use.
Induction and verification of inflammation in the tongue
Under anesthesia from an intraperitoneal injection of so-
dium pentobarbital (50 mg/kg, Schering Plough, White-
house Station, NJ, USA), 5 μL of CFA was submucosally
injected into the left side of the anterior dorsolateral
two-thirds of the tongue with a 30-gauge needle attach-
ing a Hamilton syringe (1.0 mL, Hamilton, Reno, NV,
USA). The same amount of isotonic saline was injected
as the vehicle control. Notably, during each injection,
the location of the needle was best limited in the superfi-
cial skin layer of the tongue without entering the tongue
muscle. After the injection, a small cotton swab was
placed on the injection site for 1 to 2 min to prevent any
leakage. Animals were closely monitored for evidence of
distress or pain, and weight gain following the injections.
To verify the occurrence of tongue inflammation,
rats were perfused transcardially with 250 mL 0.9%
isotonic saline followed by 500 mL ice cold 4% paraf-
ormaldehyde in 0.1 M phosphate buffer (PB, pH 7.4)
on days 8 and 15 after CFA injection. The tongues
were removed and immersed in the same fixative for 4
h at 4°C. After post-fixation, tongue tissues were em-
bedded in Tissue Tek (Sakura Finetechnical, Tokyo,
Japan), cut in the horizontal plane along the long axis
of the tongue on a cryostat at a thickness of 10 μm,
stained with hematoxylin and eosin (HE), and evaluated
microscopically.
To examine inflammatory extravasation at each specified
time point, Evans Blue solution (50 mg/kg, 10 mg/mL in
saline) was intravenously injected through the femoral vein
at 4 to 5 min before perfusion. Then rats were perfused
through the aorta with normal saline. Photographs of
tongue sections were taken, and Evans Blue stained regions
were observed under the microscope.
Behavioral testing
Rats were lightly anesthetized with 2% isoflurane (Mylan,
Morgantown, WV, USA) mixed with oxygen, and the
depth of anesthesia was assured as previously described
[24]. According to our previous reports [11,20,41,42], a
pair of bipolar enamel-coated silver-wire electrodes was
inserted into the splenius capitis muscle for electromyo-
graphic (EMG) recording (inter-electrode distance, 5 to
6 mm). The EMG activity was amplified, filtered, digi-
tized, and integrated by the Spike 2 software (CED 1401,
Cambridge Electronic Design, Cambridge, UK).
For measurement of mechanical head withdrawal
threshold (MHWT), an electronic von Frey anesthesi-
ometer (Bioseb, Chaville, France) was used to apply
graded mechanical pinch stimuli to CFA- or saline-
injected tongue. The MHWT was defined as the lowest
pressure (g) required to elicit a robust bursting activity
in neck EMG recording accompanied by a clear head
withdrawal response. The cutoff mechanical stimulus in-
tensity was 130 g. For assessment of heat head with-
drawal threshold (HHWT), heat stimulus was applied
using a contact thermal probe (25 mm2, adapted
temperature: 35°C, Intercross, Tokyo, Japan) to the
tongue. The probe temperature increased 0.3°C per sec-
ond during the assessment period. The HHWT was
defined as the minimum temperature sufficient to elicit
a drastic head escape and sudden appearance of a
bursting EMG activity. The cutoff temperature was set
at 60°C.
Both MHWT and HHWT were measured 1 day before
and on days 1, 3, 5, 8, 11, and 15 after saline or CFA in-
jection. Three measurements (at 5-min intervals) were
performed and averaged at each time point for each ani-
mal. All behavioral tests were conducted under blind
conditions.
Tissue preparation and pERK immunohistochemistry
On days 3, 8, and 15 after saline or CFA injection into
the tongue and in naive rats, noxious mechanical stimu-
lation was applied to the tongue using an arterial clip
(intensity, 120 g; duration, 30s; interval, 30s; total, 10
min) with the rats under sodium pentobarbital
anesthesia (50 mg/kg, i.p.). On the basis of our previous
results that the number of pERK-IR cells peaked at 5 min
after capsaicin injection into the tongue [12], rats were
perfused transcardially with 250 mL isotonic saline fol-
lowed by 500 mL cold 4% paraformaldehyde in 0.1 M PB
(pH 7.4) at 5 min after noxious stimulation. Furthermore,
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naive and CFA-injected rats were perfused transcardially
in the absence of noxious mechanical stimulation. The
medulla and upper cervical spinal cord were removed
and placed in the same fixative overnight at 4°C. These
tissues were transferred to 20% sucrose in 0.01 M
phosphate-buffered saline (PBS) for several days for cryo-
protection. Thirty micrometer thick sections of the me-
dulla and upper cervical spinal cord were cut with a
freezing microtome at -20°C, and every fourth section
was collected in 0.01 M PBS. Free-floating sections were
rinsed in 0.01 M PBS, blocked in 3% normal goat serum
(NGS) for 1 h at room temperature (RT), and then incu-
bated with rabbit anti-pERK (Thr202/Tyr204) antibody
(1:1,000, Cell Signaling Technology, Beverly, MA, USA)
in 3% NGS with 0.75% Triton X-100 for 72 h at 4°C.
After rinsing, sections were incubated with biotinylated
goat anti-rabbit antibody (1:600, Vector Laboratories,
Burlingame, CA, USA) for 2 h at RT. Following rinses in
0.01 M PBS, these sections were reacted with peroxidase-
conjugated avidin-biotin complex (ABC, 1:50, Vector La-
boratories) for 1 h at RT. They were washed in 0.05 M
Tris buffer (TB) and incubated with 0.035% 3,3’-diamino-
benzidine-tetra hydrochloride (DAB, Tokyo Chemical In-
dustry, Tokyo, Japan) in 0.05 M TB containing 0.2%
nickel ammonium sulfate and 0.05% hydrogen peroxide
for 3 to 4 min. Sections were finally rinsed in 0.01 M
PBS, mounted on gelatin-coated slides, air-dried, dehy-
drated in ethanol, cleared in xylene, and coverslipped. All
specific staining was abolished by omission of the pri-
mary antibody in the process.
The pERK-IR cells were counted under a light micro-
scope with an attached camera lucida drawing tube
(Neurolucida 2000, MicroBrightField, Colchester, UT,
USA). The sections were then grouped into 720 μm seg-
ments rostrocaudally with reference to the obex. In
order to analyze rostrocaudal distribution of pERK-IR
cells, the number of pERK-IR cells from three sections
at each level in Vc and C1-C2 was counted, and then
averaged from five rats in each group. The cells showing
more intense staining than the average background were
considered positive for pERK immunoreactivity. The
whole counting process was performed by an investiga-
tor blind to the experimental treatments.
Double immunofluorescence
Three rats received noxious mechanical stimulation of
the tongue by an arterial clip (intensity, 120 g; duration,
30s; interval, 30s; total, 10 min) on day 8 after CFA in-
jection into the tongue. Five min after the stimulation,
rats were perfused with 250 mL isotonic saline followed
by 500 mL cold 4% paraformaldehyde in 0.1 M PB (pH
7.4). After cryoprotection in 20% sucrose, 30 μm thick
sections were cut as described previously and processed
for double immunofluorescence labeling between pERK
or mGluR5 and the neuronal label, NeuN, or the astro-
glial label, glial fibrillary acidic protein (GFAP). We also
performed double-immunostaining between pERK and
mGluR5 antibodies. Free-floating tissue sections were
rinsed in 0.01 M PBS, blocked in 3% NGS for 1 h and
incubated with rabbit anti-pERK antibody (1:300, Cell
Signaling Technology) or goat anti-mGluR5 antibody
(1:50, Santa Cruz, CA, USA) and mouse anti-NeuN anti-
body (1:1,000, Chemicon, MA, USA), or mouse anti-
GFAP antibody (1:1000, Dako, Tokyo, Japan) for 72 h at
4°C. Similarly, free-floating tissue sections were incu-
bated with rabbit anti-pERK antibody and goat anti-
mGluR5 antibody (Merck Millipore, Billerica, MA,
USA). After rinsing in 0.01 M PBS, the sections were
incubated with the secondary antibodies (anti-rabbit or
anti-goat Alexa Fluor 488 and anti-rabbit or anti-mouse
Alexa Fluor 568, 1:1,000, Invitrogen, NY, USA) where
appropriate for 2 h at RT in a dark room. Then, the sec-
tions were rinsed in 0.01 M PBS, mounted on slides, and
coverslipped with PermaFluor (Sigma Aldrich, St. Louis,
MO, USA). The immunofluorescence images were taken
with a confocal laser scanning microscope (LSM 510
V3.2, Carl Zeiss, Tokyo, Japan).
Western blotting
On day 8 after CFA or saline injection into the tongue,
the rat was anesthetized with sodium pentobarbital
(50 mg/kg, i.p.) and perfused with saline. Medulla con-
taining Vc and C1-C2 was taken out and homogenized in
100 μL of ice-cold lysis buffer (137 mM NaCl, 20 mM
Tris-HCl, pH 8.0, 1% NP40, 10% glycerol, 1 mM phenyl-
methylsulfonyl fluoride, 10 μg/mL aprotinin, 1 g/mL
leupeptin, and 0.5 mM sodium vanadate) using a tube
pestle (Thermo Fisher Scientific, Waltham, MA, USA).
Sample was centrifuged at 15,000 rpm for 10 min at
4°C. The supernatant was collected to new tubes and
protein concentration of the sample was determined
with a protein assay kit (Bio-Rad, CA, USA). Protein
sample was heat-denatured in Laemmli sample buffer
solution (Bio-Rad). Sample (30 μg) was subjected to
electrophoresis for protein separation on 10% SDS-
PAGE and electroblotted onto polyvinylidene fluoride
membranes (Trans-Blot turb Transfer pack, Bio-Rad)
by using Trans-Blot Turbo (Bio-Rad). Following rinsing
with Tris-buffered saline containing 0.1% Tween 20
(TBST), the membrane was incubated with 3% bovine
serum albumin (BSA, Bovogen, Essendon, Australia).
The membrane was incubated overnight at 4°C with
anti-pERK antibody (1:1,000, Cell Signaling) or anti-
mGluR5 antibody (1:20,000, Merck Millipore) diluted
in TBST containing 5% BSA. Each protein binding was
visualized using a horseradish peroxidase-conjugated
donkey anti-rabbit antibody (Cell signaling) and Western
Lightning ELC Pro (Perikin Elmer, Waltham, MA, USA).
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Band intensity was quantified using a ChemiDoc MP sys-
tem (Bio-Rad) and normalized to β-actin immunoreactiv-
ity on blots reprobed with anti-β-actin antibody (1:200,
Santa Cruz) after removing protein binding using a strip-
ping reagent (Thermo Fisher Scientific).
Effects of PD98059, MPEP and CHPG on nocifensive
behavior and ERK phosphorylation
Rats were anesthetized with sodium pentobarbital
(50 mg/kg, i.p.) and placed in a stereotaxic apparatus.
After a midline skin incision, an opening was made in
the caudal part of the skull with a dental drill to insert
intrathecally a soft polyethylene tube (PE45, ID, 0.58
mm; OD, 0.96 mm; Natsume, Tokyo, Japan) [43]. The
tube was connected to a mini-osmotic pump (Alzet
model 2001, Alzet, Cupertino, CA, USA; total volume,
200 μL) filled with the drug and embedded subcutane-
ously in the dorsal portion of the body. Thus, PD98059
or MPEP was intrathecally applied for 7 days (1.0 μL/h).
The dosage and duration of the two drugs (0.1 μg/
μL) for pump infusion were chosen primarily based
on previous reports [11,20,23,39]. After completion of
the pump embedding, 5 μL of CFA solution was
injected into the anterior dorsolateral two-thirds of
the rat tongue, and the behavioral testing was per-
formed on days 1, 3, 5, 8, 11, and 15 for PD98059
treatment or on day 8 for MPEP treatment after CFA
injection. CHPG was also intrathecally applied for 7
days (0.5 μL/h) in naive rats and behavioral testing
was performed on day 8.
On day 8, CFA-treated rats with continuous PD98059
or MPEP administration received noxious mechanical
stimulation to the tongue. Five min after the stimulation,
the rats were perfused, and the pERK immunohisto-
chemistry was performed. All subsequent staining steps
and counting analysis were the same as described above.
All behavioral and immunohistochemical experiments
were conducted on animals without any obvious neuro-
logical deficits. Also, the Alzet pump was removed at the
end of each experiment, and the amount of the drug
remaining in the pump was checked. If there was still re-
sidual drug in the pump, the data from that rat were
excluded from the final analysis.
Statistical analysis
All results are presented as mean ± SEM. Statistical ana-
lyses were performed by Student’s t test, one-way
ANOVA followed by Dunnett’s multiple-comparison
tests, or two-way repeated-measures ANOVA followed
by Bonferroni’s multiple-comparison tests where appro-
priate. A value of P<0.05 was considered statistically
significant.
Results
Nocifensive behavior to mechanical or heat stimulation of
the tongue
Clear signs of local tissue inflammation with remarkable
redness and swelling of the injected site could be
observed after submucosal injection of 5 μL complete
Freund’s adjuvant (CFA) into the tongue, which lasted
for at least 2 weeks (data not shown). A significant re-
duction of mechanical head withdrawal threshold
(MHWT) was observed on the side ipsilateral to CFA in-
jection as early as day 1 after CFA injection (day 1 after
CFA injection vs. baseline, 65.7 ± 2.8 g vs. 109.7 ± 0.7 g;
n = 7, P<0.01, Figure 1A). Then, the MHWT continued
to decrease and reached the peak on day 8 (47.6 ± 3.6 g,
P<0.01). Noticeably, this CFA-induced mechanical allo-
dynia maintained until the end of the experimental
period (day 15 after CFA injection, 73.4 ± 2.0 g, P<0.01,
Figure 1A).
CFA injection into the tongue also resulted in a signifi-
cant decrease in heat head withdrawal threshold
(HHWT) (Figure 1B). HHWT was reduced on day 1
after CFA injection, peaked on day 8 (41.6 ± 0.7°C, n = 7,
P<0.01) but gradually returned to the baseline level on
day 15 (50.1 ± 0.9°C, P>0.05). Injection of the vehicle
(0.9% isotonic saline, n = 7) into the tongue did not pro-
duce any obvious alteration in either MHWT or HHWT
in any time points (Figure 1). Both groups of animals
showed normal gross behavior and weight gain during
the experimental period (data not shown). These results
suggest that CFA injection into the tongue could indeed
cause pronounced mechanical and thermal hypersensi-
tivity, thus establishing a novel behavioral model of in-
flammatory tongue pain in adult rodents.
Tongue histology
To confirm the occurrence of inflammation in the
tongue after CFA injection, hematoxylin and eosin (HE)
staining and Evans Blue staining were performed on days
8 and 15 after local CFA injection (Figure 2). The Evans
Blue experiment revealed severe signs of plasma extrava-
sation in the CFA-injected tongue on day 8, but not on
day 15 (Figure 2A, B, and C). In addition, HE staining
demonstrated a dramatic tissue infiltration of inflamma-
tory cells (for example, lymphocytes as indicated by
arrows in Figure 2Ga-Ia) in the CFA-injected tongue on
day 8 but not on day 15 (Figure 2D to I).
ERK phosphorylation in Vc and C1-C2
After verifying the new model of inflammatory tongue
pain through behavioral and histological approaches, we
next sought to elucidate possible activation (phosphoryl-
ation) of extracellular signal-regulated kinase (ERK) in
the brainstem in response to CFA-evoked persistent in-
flammatory pain. To this end, we first performed double
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immunofluorescence staining to identify the nature of
phosphorylated ERK (pERK) immunoreactive (IR) cells
induced by noxious mechanical stimulation on day 8
after CFA injection into the tongue (Figure 3). Almost
all pERK-IR cells were double stained with NeuN
(Figure 3 Aa to Ac) but not glial fibrillary acidic protein
(GFAP) (Figure 3 Ad to Af), indicating that CFA-evoked
phosphorylation of ERK is restricted to neurons.
As shown in Figure 3B, a large number pERK-IR cells
were expressed in both ipsilateral and contralateral tri-
geminal spinal subnucleus caudalis (Vc) and upper cer-
vical spinal cord (C1-C2) after noxious mechanical
stimulation of the tongue on day 3 (Figure 3 Ba and Bd),
day 8 (Figure 3 Bb and Be), and day 15 (Figure 3 Bc and
Bf) after CFA injection. The pERK-IR cells were substan-
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Figure 1 Persistent behavioral hypersensitivity induced by local injection of CFA emulsion into the tongue. Shown are the time course
of changes in mechanical head withdrawal threshold (MHWT, A) and heat head withdrawal threshold (HHWT, B) in both saline- and CFA-treated
groups. Compared with the saline control, CFA injection into the tongue elicited a significant reduction of MHWT and HHWT, with a peak
reached at 8 day after treatment. Pre: baseline. n = 7 in each group. Error bars indicate SEM.
Figure 2 Local inflammatory responses of the tongue after CFA injection. Shown are the representative histological staining of the tongue
before (A, D, G, and Ga), on day 8 (B, E, H, and Ha), and day 15 (C, F, I, and Ia) after CFA injection. A to C, Evans Blue staining; D to I, HE staining;
G to I are enlarged photographs taken from the rectangle area in D to F, respectively. CFA injection into the tongue resulted in dramatic plasma
extravasation and inflammatory cell infiltration on day 8 but not on day 15. Arrows in Ga-Ia indicate lymphocytes infiltrated into the tongue. Scale
bars: 1 mm in A to F, 200 μm in G to I, 20 μm in Ga to Ia.
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C2 where the mandibular nerve terminates [10], and
mainly segregated in the superficial layers (layer I/II),
with a few scattered in the deep layer (layer III/IV).
The rostrocaudal distribution of pERK-IR cells in the
ipsilateral and contralateral Vc and C1-C2 following sa-
line and CFA injection into the tongue is summarized in
Figure 4. The largest number of pERK-IR cells was
observed at the obex level on days 3 (Figure 4A and B),
8 (Figure 4C and D), and 15 (Figure 4E and F) after nox-
ious mechanical stimulation in CFA- or saline-injected
rats. The number of pERK-IR cells was significantly lar-
ger in CFA-injected rats compared with that of saline-
injected rats at 1,440 μm caudal from obex on day 3
(n = 5, P<0.01) and at obex on day 8 (P< 0.05) for the ip-
silateral side. The largest number of pERK-IR cells was
also observed at the obex level after noxious mechanical
stimulation in naive rats (Figure 4G and H). However,
there were no significant differences in the number of
pERK-IR cells between saline-injected and naive rats in
each segment. Moreover, pERK-IR cells were observed
in the ipsilateral (Figure 4I) and contralateral (Figure 4J)
Vc and C1-C2 on days 3, 8, and 15 after CFA injection
without noxious mechanical stimulation and also in
naive rats. The ipsilateral side of Vc and C1-C2
(Figure 4A, C, E, and G) exhibited more p-ERK-IR cells
than the contralateral side following noxious mechanical
stimulation (Figure 4B, D, F, and H).
The number of pERK-IR cells in ipsilateral Vc and
C1-C2 was significantly larger in CFA-injected rats
with noxious mechanical stimulation than that in
saline-injected rats at each time point (n = 5, Figure 5A),
though no group difference was detected in the
number of pERK-IR cells in the contralateral side
(Figure 5B). In addition, the number of pERK-IR cells
in ipsilateral (but not contralateral) Vc and C1-C2 was
still much larger in CFA-injected rats without noxious
Figure 3 Neuronal localization and bilateral distribution of pERK expression in the Vc and C1-C2. (A) Photomicrographs of ERK, NeuN and
GFAP staining in the Vc following noxious mechanical stimulation of the tongue on day 8 after CFA injection. pERK-IR was shown as green
fluorescence (Aa and Ad). NeuN and GFAP were visualized with red fluorescence (Ab and Ae). Overlap of left and middle panels revealed double
fluorescence (Ac and Af), which was only identified for p-ERK and NeuN staining, indicating the selective induction of pERK-IR in neurons. Arrows
indicate the double-labeled cells. Scale bars: 50 μm. (B) pERK-IR cells following noxious mechanical stimulation of the tongue in ipsilateral (Ba, Bb,
and Bc) and contralateral (Bd, Be, and Bf) Vc and C1-C2 on day 3 (Ba and Bd), day 8 (Bb and Be) and day 15 (Bc and Bf) after CFA injection. The
expression of pERK-IR cells was detected in both sides of Vc and C1-C2 regions with an ipsilateral dominance. Most pERK-IR cells were located in
the superficial layer and dorsomedial portion of Vc and C1-C2. Scale bars: 100 μm.
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mechanical stimulation than that in naive rats at each
time point (n = 5, Figure 5D and E). Consistently,
Western blot data showed that pERK protein expres-
sion in ipsilateral Vc and C1-C2 was dramatically
upregulated after CFA injection into the tongue
compared with saline-injected group (n = 5, P<0.05,
Figure 5C). Taken together, these data indicate that
CFA-evoked inflammatory state resulted in a much
stronger ERK activation in Vc and C1-C2 neurons in
both presence and absence of noxious mechanical
stimulation of the tongue. Furthermore, the layer and
somatotopic arrangement of pERK-IR neurons are in
line with the distribution of orally-innervated nocicep-
tive neurons in Vc and C1-C2 as reported previously
[10,12].
Effects of PD98059 on nocifensive behavior and ERK
phosphorylation
To investigate the contribution of ERK phosphorylation
in Vc and C1-C2 neurons to the development of mech-
anical allodynia and heat hyperalgesia in the tongue,
PD98059 (0.1 μg/μL) or vehicle (10% DMSO) was intra-
thecally applied to the CFA-treated rats for 7 days. Suc-
cessive intrathecal (i.t.) administration of PD98059
effectively suppressed the decrement of MHWT com-
pared with vehicle-administrated CFA-treated rats from
days 1 to 15, however, MHWT was still significantly
lower in PD98059-administrated CFA-treated rats from
days 1 to 11 compared with the threshold value before
PD98059 administration (Pre), suggesting a partial but
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Figure 4 Rostro-caudal arrangement of the mean number of pERK-IR cells evoked by noxious mechanical stimulation of the tongue
through Vc and C1-C2 both ipsilateral (A, C, and E) and contralateral (B, D, and F) to saline and CFA injection. (A) and (B), day 3; (C) and
(D), day 8; (E) and (F), day 15 after saline and CFA injection into the tongue. Rostro-caudal arrangement of the mean number of pERK-IR cells
following noxious mechanical stimulation of the tongue in ipsilateral (G) and contralateral (H) Vc and C1-C2 in naive rats. Rostro-caudal
arrangement of the mean number of pERK-IR cells in ipsilateral (I) and contralateral (J) Vc and C1-C2 in naive and CFA-injected rats without
noxious stimulation. The horizontal bars indicate the range of Vc and C1-C2 across the rostrocaudal dimension. n = 5 in each group. Error bars
indicate SEM.
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PD98059 administration (Figure 6A). Specifically, the
mean peak value of MHWT recovered from 51.0 ± 1.7 g
in vehicle control (n = 6) to 99.7 ± 4.5 g in PD98059-
treated group (n = 5, P<0.01) on day 8 after CFA injec-
tion. In contrast, HHWT was not changed on days 1 to
15 (except on day 8 ) in PD98059-treated CFA-injected
rats compared with the pre-drug baseline value, but was
indeed higher than that of vehicle-administrated CFA-
treated rats on days 3, 5, 8, and 15 (Figure 6B). The aver-
aged peak HHWT in PD98059-treated group (46.2 ±
0.3°C, n = 6) was higher than that of the vehicle control
(41.4 ± 0.3°C, n = 5, P<0.01). These results demonstrate
that the blockade of ERK phosphorylation in Vc and C1-
C2 neurons partially depressed the development of CFA-
induced mechanical allodynia and heat hyperalgesia in
the tongue. Lastly, i.t. administration of PD98059 also
caused profound suppression of pERK expression in the
ipsilateral Vc and C1-C2 on day 8 after CFA injection
(PD98059 vs. vehicle, 254.3 ± 38.6 vs. 58.3 ± 29.9; n = 3,
P<0.05), whereas no change in the number of pERK-IR
cells was observed following i.t. administration of
PD98059 in the side contralateral to the CFA injection
(Figure 6C).
Involvement of mGluR5 in ERK-mediated inflammatory
pain signaling
To evaluate the hypothesis that metabotropic glutamate
receptor 5 (mGluR5) might act as an upstream activator/
mediator in ERK-dependent inflammatory pain signaling,
we next performed the double immunofluorescence la-
beling to identify the nature of mGluR5-IR cells following
noxious mechanical stimulation of the tongue on day 8
after CFA injection. Most mGluR5-IR cells showed NeuN
immunoreactivity in Vc and C1-C2 (Figure 7A, B, and C)
and mGluR5 was expressed in a rim region of pERK-IR
cell bodies (Figure 7D, E, and F), indicating that ERK was
phosphorylated in neurons in which mGluR5 was
expressed. On day 8 after CFA injection, mGluR5 protein
expression in Vc and C1-C2 was not changed compared
with saline-treated group (Figure 7G).
Successive 2-methyl-6-(phenylethynyl)-pyridine (MPEP)
administration yielded a marked decrease in the number
of pERK-IR cells in the ipsilateral Vc and C1-C2 (MPEP
vs. vehicle, 183.7 ± 50.2 vs. 385.9 ± 49.0; n = 4, P<0.05) on
day 8 after CFA injection into the tongue (Figure 7H),
whereas no change was found in the contralateral side
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Figure 5 Quantification of the time course of pERK expression in the Vc and C1-C2 after saline and CFA injection into the tongue.
Shown is the mean number of pERK-IR cells triggered by noxious mechanical stimulation of the tongue in ipsilateral (A) and contralateral (B) Vc
and C1-C2 on days 3, 8, and 15 after saline and CFA treatment and in naive rats. (C) Normalized amount of pERK protein expression on day 8
after saline or CFA injection into the tongue. β-actin was used as a loading control. (D and E) Quantification of the time course of pERK
expression in Vc and C1-C2 neurons after CFA injection into the tongue and in naive rats without noxious stimulation. Shown is the mean
number of pERK-IR cells in ipsilateral (D) and contralateral (E) Vc and C1-C2 on days 3, 8, and 15 after CFA injection. CFA injection into the tongue
initiated a much stronger pERK expression in Vc and C1-C2 than the control group, regardless of the presence of noxious stimulation. n = 5 in
each group. Error bars indicate SEM.
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days partially but significantly suppressed the decrement
of both MHWT (MPEP vs. vehicle, 89.0 ± 2.9 g vs. 31.8 ±
2.5 g; n = 5, P<0.01) and HHWT (MPEP vs. vehicle, 46.9
± 0.1°C vs. 41.5 ± 0.4°C; n = 5, P<0.01) on day 8 after CFA
injection (Figure 8A and B). However, both MHWT and
HHWT values were still lower in MPEP-administrated
CFA-treated rats than the threshold value before CFA in-
jection (Pre) on day 8 (P<0.05), implicating an incomplete
abolishment of CFA-induced mechanical and thermal
hypersensitivity by MPEP administration. Continuous i.t.
administration of (RS)-2-Chloro-5-hydroxyphenylglycine
(CHPG) for 7 days induced the decrement of MHWT on
day 8 compared with saline-administrated group in naive
rats (CHPG vs. saline, 62.3 ± 10.9 g vs. 98.9 ± 15.5 g; n =
5, P<0.09), implicating that mGluR5 activation in Vc and
C1-C2 neurons is sufficient to induce mechanical allody-
nia in the tongue (Figure 8C).
Discussion
Inflammatory tongue pain model
In spite of previous extensive research efforts into the
pathogenesis of extra-oral pain, limited information is
now available concerning pathological pain occurring in
the tongue, which causes great difficulty in diagnosis
and treatment of tongue-related diseases (for example,
burning mouth syndrome) in the clinic [44,45] . There-
fore, it is quite necessary to devise new preclinical mod-
els of pathological tongue pain in order to gain better
understanding of the underlying mechanisms and hence
provide more effective therapeutic approaches. In this
context, several models of orofacial neuropathic pain
induced by lingual nerve injury (ligation, sectioning,
constriction, and so on) have been previously developed
and intensively characterized [46-50]. More recently, our
lab also established a new animal model of lingual
neuropathic pain by crushing the lingual nerve with an
arterial clamp (30 g, 30 s), leading to marked mechanical
allodynia and heat hyperalgesia in the tongue ipsilateral
to the nerve injury [51]. However, to date, there are only
very few papers reporting any models of inflammatory
tongue pain by injecting capsaicin [12] or formalin [8]
into the anterior part of the tongue. Moreover, in these
studies, only spontaneous pain-related behaviors (for ex-
ample, tongue protrusion, face scratching, or rubbing)
were used to indirectly evaluate the tongue pain [8]. In
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Figure 6 Effects of continuous i.t. administration of the MEK inhibitor, PD98059, on the development of mechanical allodynia and heat
hyperalgesia and CFA-induced ERK phosphorylation. Time course of changes in MHWT (A) and HHWT (B) in both vehicle- and PD98059-
treated groups. n = 5 to 6 in each group. (C) The mean number of noxious stimuli-evoked pERK-IR cells in the ipsilateral and contralateral Vc and
C1-C2 on day 8 after CFA injection into the tongue with continuous i.t. administration of PD98059 or saline. n = 3 in each group. Error bars
indicate SEM.
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Figure 7 Neuronal localization and expression of mGluR and effects of continuous i.t. administration of the mGluR5 antagonist, MPEP,
on CFA-induced ERK phosphorylation. Photomicrographs of mGluR5 (A) and NeuN (B) staining in the Vc following noxious mechanical
stimulation of the tongue on day 8 after CFA injection. (C) Overlay of the double imunofluoresence labeling, showing the neuronal nature of
mGluR5-IR cells. Arrows indicate the double-labeled cells. (D, E, F) Photomicrographs of mGluR5 (D) and pERK (E) staining in the Vc on day 8 after
CFA injection. (F) Overlay of the double imunofluoresence labeling, suggesting the colocalization of mGluR5 with pERK (arrows). (G) Normalized
amount of mGluR5 protein in Vc and C1-C2 on day 8 after saline or CFA injection into the tongue. β-actin was used as a loading control. The
mean number of noxious stimuli-triggered pERK-IR cells in the ipsilateral (H) and contralateral (I) Vc and C1-C2 on day 8 after CFA injection into
the tongue with continuous i.t. administration of MPEP or saline. MPEP administration effectively decreased CFA-induced pERK upregulation. n =
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Day 8 after injection
Figure 8 Effects of i.t. infusion of MPEP or vehicle on MHWT (A) and HHWT (B) values measured on day 8 after CFA injection into the
tongue. Successive i.t. MPEP treatment partially but significantly diminished CFA-evoked behavioral hypersensitivity. (C) Effects of i.t. 7 days
successive administration of CHPG or saline on MHWT values measured on day 8. n = 5 in each group. Error bars indicate SEM.
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methods are available to directly evaluate behavioral
phenotypes of evoked pain hypersensitivity evolving in
the tongue. Previously, behavioral and neuronal hyper-
sensitivity have been observed in some orofacial inflam-
matory pain models following CFA injection into
temporomandibular joint [1,52-54], masseter muscle
[6,55,56], or facial skin [5,57]. Thus, in the present study,
we sought for the first time to establish a novel model of
inflammatory tongue pain by injecting 5 μL CFA emul-
sion into the anterior dorsolateral two-thirds of the
tongue in adult rats.
Our results show that CFA injection into the tongue
elicited clear signs of local tissue inflammation concomi-
tant with significant reductions in MHWT and HHWT.
The results directly indicate the occurrence of mechan-
ical and heat hypersensitivity in the inflamed tongue in
rats. Interestingly, the reduction of HHWT, but not
MHWT, recovered on day 15 following CFA injection,
although the existence of thermal hyperalgesia and
mechanical allodyniafollowing CFA injection into the
upper lip/whisker pad continued for a few weeks [58]. It
is well known that the transient receptor potential vanil-
loid 1 (TRPV1), activated by noxious heat (>43°C) stim-
uli, is dominantly expressed in small-sized primary
afferent neurons and functions to modulate inflamma-
tion and pain [59-61]. Indeed, CFA-induced heat hyper-
algesia depends on functional changes in TRPV1 [62-
64]. On the other hand, one previous retrograde labeling
study showed that cell bodies of trigeminal ganglion
neurons innervating the lip are significantly smaller in
size than those innervating the tongue [8]. Therefore, it
is reasonable to speculate that the tongue is innervated
by relatively fewer numbers of small-sized TRPV1-
expressing trigeminal ganglion neurons, which may
cause the different time course between MHWT and
HHWT measurements following CFA injection into the
tongue.
Roles of pERK in Vc and C1-C2 neurons in CFA-induced
behavioral hypersensitivity
ERK is a member of the MAPK family that can be phos-
phorylated after various types of noxious stimuli [65-67].
In the trigeminal system, ERK was found to be phos-
phorylated in many Vc and C1-C2 neurons within 5 min
after capsaicin injection into various orofacial regions,
and the number of pERK-IR cells increased following
increases in the stimulus intensity [12,20,21,24]. These
findings strongly suggest that ERK phosphorylation in
Vc and C1-C2 neurons is a reliable marker of excitable
neurons following noxious stimulation of the orofacial
region. In the current study, we demonstrated that ERK
phosphorylation substantially occurred in Vc and C1-C2
neurons following noxious pinch stimulation of the
tongue, and pERK-IR neurons were mostly located in
laminae I and II, which is in line with the distribution of
nociceptive neurons in this area. Here, it is important to
note that expression of pERK-IR in Vc and C1-C2 exhib-
ited an ipsilateral dominance, although mechanical
stimulation of the tongue could also induce some pERK-
IR cells in the contralateral side. First, this bilateral dis-
tribution of pERK-IR cells is in accordance with previous
results showing bilateral terminations of mandibular
afferents in the brainstem [68]. Second, our previous
work found that injection of capsaicin into the tongue
caused a similar bilateral activation of ERK in the Vc,
consistent with the present data [12]. Third, the ipsilat-
eral dominance of pERK expression may be related to
specific injections site of the tongue according to one
previous report [69].
The pERK-IR cell expression following capsaicin injec-
tion into the whisker pad skin or masseter muscle was
restricted within a rostrocaudally narrow area in the Vc
and C1-C2. However, the distribution of pERK-IR cells
was more widespread along the rostrocaudal dimension
after capsaicin injection into the digastric and sterno-
hyoideus muscle [21]. In this study, the largest number
of pERK-IR cells was aggregated at the obex level and
distributed within a quite narrow area (-720 μm to 720
μm from obex). This rostrocaudal arrangement of
pERK-IR cells is in agreement with the observations on
ERK activation in response to capsaicin injection into
the tongue [12]. Furthermore, the number of pERK-IR
cells and the amount of pERK protein expression in ipsi-
lateral Vc and C1-C2 were significantly larger in CFA-
injected rats than those in saline-injected rats regardless
of the presence of noxious stimulation. Also, most
pERK-IR cells were located in the dorsomedial portion
of the Vc, where the third branch of the trigeminal nerve
(mandibular nerve) terminates [10]. Additionally, there
were no significant differences in the number of pERK-
IR cells induced by noxious stimulation to the tongue
between saline-injected and naive rats in each segment,
indicating that the ERK activation at the obex level
caused by saline injection is most likely due to the nox-
ious mechanical stimulation. Taken together, these find-
ings indicate that noxious primary afferents from the
tongue predominantly project to a narrow area around
the obex in the Vc with somatotopic organization. Fur-
thermore, CFA injection into the tongue modified the
excitability of nociceptive neurons in the Vc and C1-C2
by enhancing the activation of ERK irrespective of the
pre-exposure to any noxious stimulus.
Activated forms of ERK could produce exaggerated
pain sensations under both inflammatory and neuro-
pathic conditions [15,70-72]. In this respect, we found
that the number of pERK-IR cells in ipsilateral Vc and
C1-C2 was significantly larger in CFA-injected rats
than saline-injected control. Moreover, successive i.t.
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administration of the MEK1/2 inhibitor PD98059 ef-
fectively attenuated the mechanical and heat hyper-
sensitivity in CFA-injected rats, accompanied with an
apparent decrease in the number of pERK-IR neurons
in the ipsilateral Vc. These observations suggest that
the ERK pathway is involved in the enhancement of
the excitability of Vc and C1-C2 neurons following
CFA injection into the tongue, resulting in the initi-
ation and/or maintenance of mechanical and heat
hypersensitivity in the inflamed tongue.
Involvement of mGluR5 in ERK-mediated inflammatory
tongue pain
The group I mGluRs (mGluR5 and mGluR1) are
thought to play vital roles in mediation or modulation of
nociceptive transmission at different levels of the central
nerve system [73-76]. mGluR5 mRNA and its protein
are shown to be distributed in the spinal trigeminal nu-
cleus [77,78]. mGluR5 contributes to the induction of
long-term potentiation of primary afferent synaptic
transmission in the superficial layer of the Vc [33], and
modulates inflammatory nociceptive plasticity via down-
stream activation of ERK signaling in the spinal cord
[34-36]. The amount of glutamate which is an endogen-
ous ligand of mGluR5 increases in the dorsal horn fol-
lowing peripheral injection of inflammatory agents [79].
All of these previous findings make it very likely that
mGluR5 serves as an upstream activator for CFA-
induced ERK phosphorylation. Supporting this hypoth-
esis, we documented that mGluR5 was colocalized with
pERK in Vc and C1-C2 neurons. Moreover, continuous
i.t. administration of the selective mGluR5 antagonist
MPEP significantly blocked CFA-evoked mechanical and
heat hypersensitivity in the inflamed tongue and reduced
the number of pERK-IR cells in ipsilateral Vc and C1-
C2. On the other hand, direct mGluR5 activation by i.t.
CHPG administration induced mechanical allodynia in
the tongue in naive rats. The present findings suggest
that the mGluR5 activation in Vc and C1-C2 neurons by
CFA-evoked glutamate release in the dorsal horn med-
iates ERK phosphorylation, and then Vc and C1-C2
neuronal excitability is enhanced, leading to mechanical
and heat hypersensitivity in the rats with CFA injection
into the tongue.
However, pre-treatment with i.t. administration of
MPEP failed to completely abolish the upregulation of
pERK-IR cells and the reduction of MHWT and HHWT
on day 8 after CFA injection into the tongue, indicating
that there are other upstream activators for neuronal
hyperexcitability in Vc and C1-C2. For instance, ionotro-
pic glutamate receptors and some other protein kinases
play an important role in ERK-mediated enhancement of
neuronal excitability in the dorsal horn [11,66,80]. In
addition, inflammation-evoked ERK activation, which is
required for nociceptive plasticity, is also the down-
stream of mGluR1 [36]. Antisense oligonucleotide
knockdown of spinal mGluR1 attenuates heat hyperalge-
sia and mechanical allodynia in rats with CFA injection
into the hindpaw [81]. Future studies are thus warranted
to explore these possibilities and to dissect the candidate
downstream effectors of ERK signaling responsible for
the CFA-induced inflammatory nociceptive hypersensi-
tivity in the tongue.
Conclusions
The present study established a novel animal model of
inflammatory tongue pain in rats, and explored potential
roles of the mGluR5-ERK signaling in the development
of mechanical and heat hypersensitivity that evolved in
the inflamed tongue. Further elucidation of the mechan-
isms underlying this model of pathological tongue pain
may shed new light on the pathogenesis and therapeutic
strategies of some clinically relevant, tongue-associated
diseases such as burning mouth syndrome.
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